Protocol for a Randomized Controlled Trial of Platelet Aggregation Function Guiding Precise Antiplatelet Therapy for Ischemic Stroke: Rationale and Design of the PATH STROKE Study
PATH STROKE is the first clinical trial to evaluate a platelet function-guided, precision medicine, strategy for secondary prevention in ischemic stroke.
Authors
- Craig S. Anderson (ORCID: https://orcid.org/0000-0002-7248-4863)
- Song He (ORCID: https://orcid.org/0000-0002-9534-3844)
- Xia Wang (ORCID: https://orcid.org/0000-0002-1684-7076)
- Quandan Tan
- R. K. Gang
- Guoliang Zhu (ORCID: https://orcid.org/0000-0001-6728-8641)
- Yapeng Lin (ORCID: https://orcid.org/0000-0001-6303-2964)
- Neng-Wei Yu (ORCID: https://orcid.org/0000-0001-8761-7449)
- Hisatomi Arima (ORCID: https://orcid.org/0000-0002-2064-2014)
- Jie Yang (ORCID: https://orcid.org/0000-0002-9032-5348)
- Ying Luo (ORCID: https://orcid.org/0000-0002-2973-6869)
Institutions
- University of Electronic Science and Technology of China (CN)
- Chengdu Medical College (CN)
- Fudan University (CN)
- Royal Prince Alfred Hospital (AU)
- UNSW Sydney (AU)
- Fukuoka University (JP)
- Shanghai Institute for Science of Science (CN)
- Sichuan Provincial Architectural Design and Research Institute (China) (CN)
- The George Institute for Global Health (AU)
- First Affiliated Hospital of Chengdu Medical College (CN)
- Hanzhong Central Hospital (CN)
- Shanghai Center for Brain Science and Brain-Inspired Technology (CN)
Publication Details
- Journal
- Cerebrovascular Diseases
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1159/000550142
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00